|Articles|July 19, 2002
CDER's Experience: What We Have Learned from The Pediatric Initiative
19 JULY -
Advertisement
CDER's Experience: What We Have Learned from The Pediatric Initiative --William Rodriguez, M.D.http://www.fda.gov/cder/pediatric/presentation/ped_init_rodriguez/index.htm
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
4
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
5